16.12.2012 Views

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Publication After 18 months<br />

The following Patent application have been published under Section 11A <strong>of</strong> the <strong>Patents</strong><br />

(Amendment) Act, <strong>2005</strong><br />

(21) Application No.: 592/MUMNP/2004<br />

(PCT/CN03/00290)<br />

(54)<br />

A (22) Date <strong>of</strong> filing <strong>of</strong> Application: 21/10/2004<br />

Title <strong>of</strong> the invention: AN INJECTION MADE FROM LXERIS SONCHIFOLIA HANCE FO<br />

TREATMENT OF CARDIO-CEREBRAL VASCULAR DISEASES AND FUNDS DISEASES<br />

AND METHOD OF PRODUCING THEROF<br />

(51) International classification: A6K 35/78, 9/19 (71)<br />

(30) Priority Data:<br />

(31) Document No: 02109532.9<br />

(32) Date: 23.04.2002<br />

(33) Name <strong>of</strong> convention country: CHINA<br />

(66) Filed U/s. 5(2): NO.<br />

(61) Patent <strong>of</strong> addition to application No.: NIL<br />

(62) Filed on: N.A.<br />

(63) Divisional to Application No.: NIL<br />

(64) Filed on: N.A.<br />

(72)<br />

Name <strong>of</strong> the Applicant:<br />

MAOXIANG WANG A CHINE<br />

NATIONAL<br />

Address <strong>of</strong> the Applicant:<br />

1# 2-B 008-6 ROOM,<br />

WAIHUAN NORTH ROAD, TLANJIN<br />

AERO-PORT GOODS PROCESS ARE<br />

TIANJIN 3000456, P.R. CHINA<br />

Name <strong>of</strong> the Inventors:<br />

RUIXLANG ZHANG<br />

(57) Abstract: The invention discloses an injection made from Chinese herb lxeris Sonchifolia<br />

Hance for treatment <strong>of</strong> Cardio-cerebral vascular diseases <strong>and</strong> funds diseases <strong>and</strong> method <strong>of</strong><br />

producing there<strong>of</strong>. The injection is in a form <strong>of</strong> lyophilized powder in which the rate <strong>of</strong> flavone to<br />

adenosine is 5mg; 15ug or 5mg;30u. The flvone <strong>and</strong> adenosine from lxeris Sonchifolia Hance is<br />

more stable in the lyophilized powder from than in liquid form for injection so that it is easy to<br />

control the quality <strong>of</strong> the product so as to make the medicament safe <strong>and</strong> effective. It has benefit in<br />

store.<br />

Figure: NIL<br />

The Patent Office Journal <strong>24</strong>.<strong>06</strong>.<strong>2005</strong> 17989

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!